Sponsor

sigma-tau i.f.r. S.p.A.

Clinical research sponsor

Published trials3

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

3 shown

131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer PatientsNCT02602067 · lead sponsor · 2015-11-01

TERMINATED

A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic FunctionNCT00616161 · lead sponsor · 2006-08-01

COMPLETED

Efficacy of Rostafuroxin in the Treatment of Essential HypertensionNCT00415038 · lead sponsor · 2005-02-01

COMPLETED

Sponsor roles

lead sponsor3

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.